Serum Cholesterol Levels Are Underevaluated and Undertreated
- 1 June 1998
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 81 (11) , 1353-1356
- https://doi.org/10.1016/s0002-9149(98)00167-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Suboptimal Outcome of Management of Metabolic Cardiovascular Risk Factors in Hispanic Patients With Essential HypertensionHypertension, 1995
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical eventsJournal of the American College of Cardiology, 1995
- Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.Circulation, 1994
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Recent Trends in the Identification and Treatment of High Blood Cholesterol by PhysiciansJAMA, 1993
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984